These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 37239313)

  • 1. Neuroprotective Peptides and New Strategies for Ischemic Stroke Drug Discoveries.
    Dergunova LV; Filippenkov IB; Limborska SA; Myasoedov NF
    Genes (Basel); 2023 Apr; 14(5):. PubMed ID: 37239313
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic targets of neuroprotection and neurorestoration in ischemic stroke: Applications for natural compounds from medicinal herbs.
    Zhu T; Wang L; Wang LP; Wan Q
    Biomed Pharmacother; 2022 Apr; 148():112719. PubMed ID: 35168073
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms of neuronal cell death in ischemic stroke and their therapeutic implications.
    Tuo QZ; Zhang ST; Lei P
    Med Res Rev; 2022 Jan; 42(1):259-305. PubMed ID: 33957000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The erythropoietin-derived peptide MK-X and erythropoietin have neuroprotective effects against ischemic brain damage.
    Yoo SJ; Cho B; Lee D; Son G; Lee YB; Soo Han H; Kim E; Moon C; Moon C
    Cell Death Dis; 2017 Aug; 8(8):e3003. PubMed ID: 28817120
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuroprotective Strategies for Stroke by Natural Products: Advances and Perspectives.
    Liu A; Hu J; Yeh TS; Wang C; Tang J; Huang X; Chen B; Huangfu L; Yu W; Zhang L
    Curr Neuropharmacol; 2023; 21(11):2283-2309. PubMed ID: 37458258
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitochondria and neuroprotection in stroke: Cationic arginine-rich peptides (CARPs) as a novel class of mitochondria-targeted neuroprotective therapeutics.
    MacDougall G; Anderton RS; Mastaglia FL; Knuckey NW; Meloni BP
    Neurobiol Dis; 2019 Jan; 121():17-33. PubMed ID: 30218759
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroprotective Strategies for Ischemic Stroke-Future Perspectives.
    Haupt M; Gerner ST; Bähr M; Doeppner TR
    Int J Mol Sci; 2023 Feb; 24(5):. PubMed ID: 36901765
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical efficacy of neuropeptides in cerebrovascular pathology].
    Shavlovskaya OA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2016; 116(8):88-93. PubMed ID: 28635743
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The application of nanoparticles for neuroprotection in acute ischemic stroke.
    Chen L; Gao X
    Ther Deliv; 2017 Oct; 8(10):915-928. PubMed ID: 28944741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Thrombin-Activated Peptide-Templated Nanozyme for Remedying Ischemic Stroke via Thrombolytic and Neuroprotective Actions.
    Wang Z; Zhao Y; Hou Y; Tang G; Zhang R; Yang Y; Yan X; Fan K
    Adv Mater; 2024 Mar; 36(10):e2210144. PubMed ID: 36730098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuron protection as a therapeutic target in acute ischemic stroke.
    Tuttolomondo A; Di Sciacca R; Di Raimondo D; Arnao V; Renda C; Pinto A; Licata G
    Curr Top Med Chem; 2009; 9(14):1317-34. PubMed ID: 19849659
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeted delivery of intranasally administered nanoparticles-mediated neuroprotective peptide NR2B9c to brain and neuron for treatment of ischemic stroke.
    Li R; Huang Y; Chen L; Zhou H; Zhang M; Chang L; Shen H; Zhou M; Su P; Zhu D
    Nanomedicine; 2019 Jun; 18():380-390. PubMed ID: 30428334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emerging neuroprotective strategies for the treatment of ischemic stroke: An overview of clinical and preclinical studies.
    Paul S; Candelario-Jalil E
    Exp Neurol; 2021 Jan; 335():113518. PubMed ID: 33144066
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Understanding the Pathophysiology of Ischemic Stroke: The Basis of Current Therapies and Opportunity for New Ones.
    Salaudeen MA; Bello N; Danraka RN; Ammani ML
    Biomolecules; 2024 Mar; 14(3):. PubMed ID: 38540725
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nanomedicinal Strategies as Emerging Therapeutic Avenues to Treat and Manage Cerebral Ischemia.
    Fatima S; Quadri SN; Parveen S; Beg S; Barkat MA; Samim M; Abdin MZ; Ahmad FJ
    CNS Neurol Disord Drug Targets; 2021; 20(2):125-144. PubMed ID: 33138766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current status and perspectives of neuroprotection in ischemic stroke treatment.
    Martínez-Vila E; Sieira PI
    Cerebrovasc Dis; 2001; 11 Suppl 1():60-70. PubMed ID: 11244202
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel brain-targeting 3-n-butylphthalide prodrugs for ischemic stroke treatment.
    Xiang H; Zhang Q; Han Y; Yang L; Zhang Y; Liu Q; Zhang Z; Zhang L
    J Control Release; 2021 Jul; 335():498-514. PubMed ID: 34087248
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advanced drug delivery system against ischemic stroke.
    Zhang S; Zhou Y; Li R; Chen Z; Fan X
    J Control Release; 2022 Apr; 344():173-201. PubMed ID: 35248645
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nanoparticles-mediated emerging approaches for effective treatment of ischemic stroke.
    He W; Zhang Z; Sha X
    Biomaterials; 2021 Oct; 277():121111. PubMed ID: 34488117
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Restoration of early deficiency of axonal guidance signaling by guanxinning injection as a novel therapeutic option for acute ischemic stroke.
    Xiao G; Lyu M; Li Z; Cao L; Liu X; Wang Y; He S; Chen Z; Du H; Feng Y; Wang J; Zhu Y
    Pharmacol Res; 2021 Mar; 165():105460. PubMed ID: 33513357
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.